IRRAS AB (publ) Stock London S.E.
Equities
0GDW
SE0008321202
Medical Equipment, Supplies & Distribution
Sales 2023 * | 165M 15.66M 21.41M | Sales 2024 * | 249M 23.59M 32.25M | Capitalization | 182M 17.25M 23.59M |
---|---|---|---|---|---|
Net income 2023 * | -101M -9.59M -13.11M | Net income 2024 * | -29M -2.75M -3.76M | EV / Sales 2023 * | 2.38 x |
Net Debt 2023 * | 211M 20M 27.34M | Net Debt 2024 * | 258M 24.47M 33.46M | EV / Sales 2024 * | 1.77 x |
P/E ratio 2023 * |
-0.13
x | P/E ratio 2024 * |
-0.43
x | Employees | 47 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 3.55% |
Latest transcript on IRRAS AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Will Martin
CEO | Chief Executive Officer | 49 | 17-12-31 |
Griffen Stapp
DFI | Director of Finance/CFO | 38 | - |
Director/Board Member | 66 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marios Fotiadis
CHM | Chairman | 51 | 11-12-31 |
Director/Board Member | 66 | 15-05-31 | |
Director/Board Member | 69 | 17-08-31 |
1st Jan change | Capi. | |
---|---|---|
+11.34% | 127B | |
-0.56% | 12B | |
-20.95% | 6.88B | |
+58.12% | 6.86B | |
+9.22% | 3.47B | |
-17.21% | 2.54B | |
-18.86% | 1.9B | |
-28.80% | 1.58B | |
-38.19% | 1.43B |